Výsledky vyhledávání - "W E E, Eberhardt"

Management strategies for oligometastatic lung cancer

Autor: J. Pfannschmidt, M. Guckenberger, W. E. E. Eberhardt

Publikováno v: Wiener klinisches Magazin.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d1e8f48576b71c272bd04d75d4da63d
https://doi.org/10.1007/s00740-023-00495-y

Zobrazit plný text záznamu

Prospektiv-randomisierte Phase-II-Studie zur Induktionschemotherapie und Radiochemotherapie ± Durvalumab gefolgt von Operation und Durvalumab-Konsolidierung beim resektablen NSCLC III (ESPADURVA)

Autor: W. E. E. Eberhardt, C. Aigner, K. Darwiche, M. Stuschke

Publikováno v: Forum. 37:62-64

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dc7cae1696cfc23e3931b9af529b8bb4
https://doi.org/10.1007/s12312-021-01024-w

Zobrazit plný text záznamu

Immunoncology : The gentle Revolution of Cancer Medicine?

Autor: W. E. E. Eberhardt, H. Schmidberger, M. Heiss

Publikováno v: Der Onkologe. 23:790-792

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::555389b632af88cb361acc8ba5616327
https://doi.org/10.1007/s00761-017-0289-4

Zobrazit plný text záznamu

[Subgroup Analysis of the Non-interventional REASON Study: PFS and OS According to Age, Smoking History, Gender, and Histology in NSCLC Patients Treated with Gefitinib or Chemotherapy]

Autor: W, Schuette, W E E, Eberhardt, C, Waller, P, Schirmacher, M, Dietel, U, Zirrgiebel, S, Radke, M, Thomas

Publikováno v: Pneumologie (Stuttgart, Germany). 70(9)

Assessment of several clinical factors on progression-free (PFS) and overall survival (OS) in NSCLC patients (pts.) (stage IV) with mutated epidermal growth factor receptor (EGFRm+) treated with gefitinib (gef) or with chemotherapy (CT) under real-wo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b4701817e7126527aba87a7a5884ad72
https://pubmed.ncbi.nlm.nih.gov/27603946

Zobrazit plný text záznamu